Endo International PLC  

(Public, NASDAQ:ENDP)   Watch this stock  
Find more results for ENDP
57.70
+1.42 (2.52%)
After Hours: 57.70 0.00 (0.00%)
Apr 16, 5:43PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 55.41 - 57.75
52 week 32.66 - 82.16
Open 57.24
Vol / Avg. 4.00M/3.31M
Mkt cap 8.76B
P/E     -
Div/yield     -
EPS -4.73
Shares 151.77M
Beta 1.00
Inst. own 83%
May 19, 2014
Endo Health Solutions Inc. Annual Shareholder Meeting (Estimated) Add to calendar
May 1, 2014
Q1 2014 Endo Health Solutions Inc. Earnings Release - 9:30AM EDT - Add to calendar
May 1, 2014
Q1 2014 Endo International PLC Earnings Conference Call - 7:30AM EDT - Add to calendar
Feb 28, 2014
Q4 2013 Endo Health Solutions Inc. Earnings Release
Feb 28, 2014
Q4 2013 Endo Health Solutions Inc. Earnings Conference Call - Webcast
Feb 24, 2014
Paladin Labs Inc Extraordinary Special Meeting Shareholder Meeting
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -155.72% -20.46%
Operating margin -168.60% -14.77%
EBITD margin - 35.98%
Return on average assets -40.06% -8.15%
Return on average equity -272.58% -66.98%
Employees 3,371 -
CDP Score - -

Address

25-28 North Wall Quay, DUBLIN 1
DUBLIN,
Ireland
+353-1-6492000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Endo International PLC, formerly Endo Health Solutions Inc., is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm , Opana ER, Voltaren Gel, Percocet , Frova , Supprelin LA, Vantas , Valstar and Fortesta Gel. The Company operates in three segments: Endo Pharmaceuticals, Qualitest and AMS. In February 2014, the Company completed the divestiture of HealthTronics to Altaris Capital Partners, LLC. Effective February 28, 2014, acquired the entire share capital of Paladin Labs Inc.